![](/img/cover-not-exists.png)
TIDEL-II : fi rst-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets
Yeung, David T, Osborn, Michael P, White, Deborah L, Branford, Susan, Braley, Jodi, Herschtal, Alan, Kornhauser, Michael, Issa, Samar, Hiwase, Devendra K, Hertzberg, Mark, Schwarer, Anthony P, FilshieVolume:
125
Year:
2015
Language:
english
DOI:
10.1182/blood-2014-07-590315.Presented
File:
PDF, 966 KB
english, 2015